Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.

Yin JJ, Sharma S, Shumyak SP, Wang ZX, Zhou ZW, Zhang Y, Guo P, Li CZ, Kanwar JR, Yang T, Mohapatra SS, Liu W, Duan W, Wang JC, Li Q, Zhang X, Tan J, Jia L, Liang J, Wei MQ, Li X, Zhou SF.

PLoS One. 2013 May 2;8(5):e62289. doi: 10.1371/journal.pone.0062289. Print 2013.

2.

Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.

Xu J, Xu B, Shou D, Qin F, Xu Y, Hu Y.

Eur J Pharm Sci. 2016 Feb 15;83:132-42. doi: 10.1016/j.ejps.2015.11.008. Epub 2015 Nov 12.

PMID:
26577995
3.

Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.

Mizusako H, Tagami T, Hattori K, Ozeki T.

J Pharm Sci. 2015 Sep;104(9):2934-40. doi: 10.1002/jps.24428. Epub 2015 May 4.

PMID:
25940848
4.

Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.

Chiu CC, Lin YT, Sun SL, Sung KH, Wang LF.

J Biomater Sci Polym Ed. 2011;22(11):1487-507. doi: 10.1163/092050610X512414. Epub 2010 Jul 12.

PMID:
20626956
5.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
6.
7.

Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.

Cao W, Zhou J, Mann A, Wang Y, Zhu L.

Biomacromolecules. 2011 Jul 11;12(7):2697-707. doi: 10.1021/bm200487h. Epub 2011 Jun 9.

PMID:
21619062
8.
9.

Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.

Su C, Li H, Shi Y, Wang G, Liu L, Zhao L, Su R.

Int J Pharm. 2014 Oct 20;474(1-2):202-11. doi: 10.1016/j.ijpharm.2014.08.026. Epub 2014 Aug 19.

PMID:
25149123
10.

Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.

Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.

Bioconjug Chem. 2013 Apr 17;24(4):724-33. doi: 10.1021/bc400015r. Epub 2013 Mar 15.

PMID:
23458386
11.

Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.

Shen Z, Li Y, Kohama K, Oneill B, Bi J.

Pharmacol Res. 2011 Jan;63(1):51-8. doi: 10.1016/j.phrs.2010.10.012. Epub 2010 Oct 28.

PMID:
21035550
12.

Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.

Zhang H, Cai Z, Sun Y, Yu F, Chen Y, Sun B.

J Biomed Mater Res A. 2012 Sep;100(9):2441-9. doi: 10.1002/jbm.a.34169. Epub 2012 May 5.

PMID:
22566147
13.

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.

Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.

Biomaterials. 2010 Jul;31(21):5634-42. doi: 10.1016/j.biomaterials.2010.03.066. Epub 2010 Apr 28.

PMID:
20430433
14.

Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs.

Feng S, Zhang H, Yan T, Huang D, Zhi C, Nakanishi H, Gao XD.

Int J Nanomedicine. 2016 Sep 12;11:4573-4582. eCollection 2016.

15.

Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.

Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.

Eur J Pharm Biopharm. 2010 Sep;76(1):10-6. doi: 10.1016/j.ejpb.2010.05.005. Epub 2010 May 22.

PMID:
20472060
16.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
17.

Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.

Alibolandi M, Abnous K, Sadeghi F, Hosseinkhani H, Ramezani M, Hadizadeh F.

Int J Pharm. 2016 Mar 16;500(1-2):162-78. doi: 10.1016/j.ijpharm.2016.01.040. Epub 2016 Jan 21.

PMID:
26802496
18.

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Qiu LY, Yan L, Zhang L, Jin YM, Zhao QH.

Int J Pharm. 2013 Nov 18;456(2):315-24. doi: 10.1016/j.ijpharm.2013.08.071. Epub 2013 Sep 7.

PMID:
24016742
19.

Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.

Ye WL, Teng ZH, Liu DZ, Cui H, Liu M, Cheng Y, Yang TH, Mei QB, Zhou SY.

J Pharm Sci. 2013 Feb;102(2):530-40. doi: 10.1002/jps.23381. Epub 2012 Nov 20.

PMID:
23169439
20.

Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.

Zhang L, Lu J, Jin Y, Qiu L.

Colloids Surf B Biointerfaces. 2014 Oct 1;122:260-9. doi: 10.1016/j.colsurfb.2014.07.005. Epub 2014 Jul 10.

PMID:
25058857

Supplemental Content

Support Center